168 related articles for article (PubMed ID: 19362969)
1. High-resolution genomic analysis in Waldenström's macroglobulinemia identifies disease-specific and common abnormalities with marginal zone lymphomas.
Braggio E; Keats JJ; Leleu X; Wier SV; Jimenez-Zepeda VH; Schop RF; Chesi M; Barrett M; Stewart AK; Dogan A; Bergsagel PL; Ghobrial IM; Fonseca R
Clin Lymphoma Myeloma; 2009 Mar; 9(1):39-42. PubMed ID: 19362969
[TBL] [Abstract][Full Text] [Related]
2. Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia.
Braggio E; Keats JJ; Leleu X; Van Wier S; Jimenez-Zepeda VH; Valdez R; Schop RF; Price-Troska T; Henderson K; Sacco A; Azab F; Greipp P; Gertz M; Hayman S; Rajkumar SV; Carpten J; Chesi M; Barrett M; Stewart AK; Dogan A; Bergsagel PL; Ghobrial IM; Fonseca R
Cancer Res; 2009 Apr; 69(8):3579-88. PubMed ID: 19351844
[TBL] [Abstract][Full Text] [Related]
3. Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities.
Braggio E; Dogan A; Keats JJ; Chng WJ; Huang G; Matthews JM; Maurer MJ; Law ME; Bosler DS; Barrett M; Lossos IS; Witzig TE; Fonseca R
Mod Pathol; 2012 May; 25(5):651-60. PubMed ID: 22301699
[TBL] [Abstract][Full Text] [Related]
4. Genomic abnormalities of Waldenström macroglobulinemia and related low-grade B-cell lymphomas.
Braggio E; Fonseca R
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):198-201. PubMed ID: 23477936
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma.
Ocio EM; Hernandez JM; Mateo G; Sanchez ML; Gonzalez B; Vidriales B; Gutierrez NC; Orfao A; San Miguel JF
Clin Lymphoma; 2005 Mar; 5(4):241-5. PubMed ID: 15794856
[TBL] [Abstract][Full Text] [Related]
6. Isochromosome (6p) in Waldenstrom's macroglobulinemia.
White AD; Clark RE; Jacobs A
Cancer Genet Cytogenet; 1992 Jan; 58(1):89-91. PubMed ID: 1728957
[TBL] [Abstract][Full Text] [Related]
7. Clonal chromosome abnormalities in patients with Waldenström's and CLL-associated macroglobulinemia: significance of trisomy 12.
Han T; Sadamori N; Takeuchi J; Ozer H; Henderson ES; Bhargava A; Fitzpatrick J; Sandberg AA
Blood; 1983 Sep; 62(3):525-31. PubMed ID: 6411149
[TBL] [Abstract][Full Text] [Related]
8. Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression.
Amaador K; Vos JMI; Pals ST; Kraan W; Dobber JA; Minnema MC; Koene HR; de Bruin PC; Zwinderman AH; Kersten MJ
Leuk Lymphoma; 2022 May; 63(5):1070-1079. PubMed ID: 34961399
[TBL] [Abstract][Full Text] [Related]
9. High-throughput genomic analysis in Waldenström's macroglobulinemia.
Poulain S; Braggio E; Roumier C; Aijjou R; Broucqsault N; Galiègue-Zouitina S; Manier S; Soenen V; Nibourel O; Duthilleul P; Fonseca R; Leleu X
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):106-8. PubMed ID: 21454205
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide array-based comparative genomic hybridization of ocular marginal zone B cell lymphoma: comparison with pulmonary and nodal marginal zone B cell lymphoma.
Kim WS; Honma K; Karnan S; Tagawa H; Kim YD; Oh YL; Seto M; Ko YH
Genes Chromosomes Cancer; 2007 Aug; 46(8):776-83. PubMed ID: 17492759
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia.
Nguyen-Khac F; Lambert J; Chapiro E; Grelier A; Mould S; Barin C; Daudignon A; Gachard N; Struski S; Henry C; Penther D; Mossafa H; Andrieux J; Eclache V; Bilhou-Nabera C; Luquet I; Terre C; Baranger L; Mugneret F; Chiesa J; Mozziconacci MJ; Callet-Bauchu E; Veronese L; Blons H; Owen R; Lejeune J; Chevret S; Merle-Beral H; Leblondon V; ; ;
Haematologica; 2013 Apr; 98(4):649-54. PubMed ID: 23065509
[TBL] [Abstract][Full Text] [Related]
12. Chromosome changes in 19 patients with Waldenström's macroglobulinemia.
Palka G; Spadano A; Geraci L; Fioritoni G; Dragani A; Calabrese G; Guanciali Franchi P; Stuppia L
Cancer Genet Cytogenet; 1987 Dec; 29(2):261-9. PubMed ID: 3119188
[TBL] [Abstract][Full Text] [Related]
13. Genetic factors and pathogenesis of Waldenström's macroglobulinemia.
Monge J; Braggio E; Ansell SM
Curr Oncol Rep; 2013 Oct; 15(5):450-6. PubMed ID: 23901022
[TBL] [Abstract][Full Text] [Related]
14. G-banding and molecular cytogenetic analyses of marginal zone lymphoma.
Aamot HV; Micci F; Holte H; Delabie J; Heim S
Br J Haematol; 2005 Sep; 130(6):890-901. PubMed ID: 16156859
[TBL] [Abstract][Full Text] [Related]
15. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
[TBL] [Abstract][Full Text] [Related]
16. Recent updates in the indolent lymphomas: Update on marginal zone lymphoma and Waldenström's macroglobulinemia.
Amaador K; Thieblemont C; Trotman J; Minnema MC
Hematol Oncol; 2023 Jul; ():. PubMed ID: 37458281
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetics of familial Waldenstrom's macroglobulinemia: in pursuit of an understanding of genetic predisposition.
McMaster ML; Giambarresi T; Vasquez L; Goldstein AM; Tucker MA
Clin Lymphoma; 2005 Mar; 5(4):230-4. PubMed ID: 15794854
[TBL] [Abstract][Full Text] [Related]
18. A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenström's macroglobulinemia.
Panayiotidis P; Tumyan G; Thieblemont C; Ptushkin VV; Marin-Niebla A; García-Sanz R; Le Gouill S; Stathis A; Bottos A; Hamidi H; Katz P; Perretti T; Willis JC; Buske C
Leuk Lymphoma; 2022 May; 63(5):1058-1069. PubMed ID: 35045765
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases.
Callet-Bauchu E; Baseggio L; Felman P; Traverse-Glehen A; Berger F; Morel D; Gazzo S; Poncet C; Thieblemont C; Coiffier B; Magaud JP; Salles G
Leukemia; 2005 Oct; 19(10):1818-23. PubMed ID: 16094418
[TBL] [Abstract][Full Text] [Related]
20. Complex karyotype including 14q+ marker in a case of Waldenström's macroglobulinemia.
Cigudosa JC; Calasanz MJ; Pérez C; Rifón J; Cuesta B; Gullon A
Cancer Genet Cytogenet; 1994 Apr; 73(2):169-70. PubMed ID: 8174094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]